Atossa Therapeutics, Inc. (ATOS)
NASDAQ: ATOS · IEX Real-Time Price · USD
1.160
-0.040 (-3.33%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Atossa Therapeutics Analyst Ratings
Total Analysts
3
Consensus Rating
Strong Buy
Price Target
$6.13
Upside
+428.45%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 20, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $6 → $6.25 | Strong Buy | Maintains | $6 → $6.25 | +438.79% | Jun 6, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | May 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $4 → $6 | Strong Buy | Maintains | $4 → $6 | +417.24% | May 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +244.83% | Apr 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $4 | Strong Buy | Maintains | $4 | +244.83% | Apr 2, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +244.83% | Feb 12, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $5 | Buy | Initiates | $5 | +331.03% | Sep 8, 2023 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Dec 18, 2019 |